Showing 1 - 10 results of 10 for search '"SARS-CoV-2 immunology"', query time: 0.95s Refine Results
1
SARS-CoV-2 vaccines–induced thrombotic thrombocytopenia: should we consider immuno-hypersensitivity?

Authors: Reuben, Rine Christopher, Adogo, Lillian Yami

Source: Revista de Saúde Pública

Subject Terms: Comment, COVID-19, prevention & control, SARS-CoV-2, immunology, COVID-19 Vaccines, Immunogenicity, Vaccine, Embolism and Thrombosis

Access URL: https://explore.openaire.eu/search/publication?articleId=pmc_________::a2b1a60f1f4baa04c7d44ca4f334ba2d
http://europepmc.org/articles/PMC8522756

4
Diagnosis options in patients suffering from COVID‐19‐like symptoms

Authors: Nicolas Sans, Jacques Izopet, Samia Collot, Marie Faruch, Sébastien Lhomme, Florence Abravanel, Karine Sauné, Chloé Dimeglio

Contributors: Centre de Physiopathologie Toulouse Purpan (CPTP), Université Toulouse III - Paul Sabatier (UT3), Université Fédérale Toulouse Midi-Pyrénées-Université Fédérale Toulouse Midi-Pyrénées-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS), Laboratoire de Virologie [Toulouse], CHU Toulouse [Toulouse]

Source: Journal of Medical Virology
Journal of Medical Virology, Wiley-Blackwell, 2021, 93 (7), pp.4076-4077. ⟨10.1002/jmv.26724⟩

Subject Terms: MESH: Antibodies, Viral / blood, MESH: COVID-19 / diagnosis, MESH: COVID-19 / diagnostic imaging, MESH: COVID-19 Nucleic Acid Testing, MESH: False Positive Reactions, MESH: Humans, MESH: Lung / diagnostic imaging, MESH: SARS-CoV-2 / immunology, MESH: Tomography, X-Ray Computed, [SDV.MHEP.MI]Life Sciences [q-bio]/Human health and pathology/Infectious diseases, Infectious Diseases, Virology, 2019-20 coronavirus outbreak, Computed tomography, medicine.diagnostic_test, medicine, Coronavirus disease 2019 (COVID-19), Chest ct, Radiology, medicine.medical_specialty, Serology, In patient, business.industry, business, Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), Medical diagnosis

Access URL: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::259ad6ee53abc67f1638faec01aa9305
https://hal.archives-ouvertes.fr/hal-03282691

5
When Therapeutic IgA Antibodies Might Come of Age

Authors: Sterlin, Delphine, Gorochov, Guy

Contributors: Anticorps en thérapie et pathologie - Antibodies in Therapy and Pathology, Institut National de la Santé et de la Recherche Médicale (INSERM)-Institut Pasteur [Paris], Centre d'Immunologie et de Maladies Infectieuses (CIMI), Institut National de la Santé et de la Recherche Médicale (INSERM)-Sorbonne Université (SU)-Centre National de la Recherche Scientifique (CNRS), D.S. was supported for this work by an Institut Pasteur/Assistance Publique – Hôpitaux de Paris (APHP) interface fellowship. The Gorochov Laboratory is financed by Inserm, APHP (PHRC-20-0375), Sorbonne Université (SARS-CoV-2 Program), Région Île de France Domaines d’Intérêt Majeur (DIM Thérapie Génique), Fondation de France, and Agence Nationale de la Recherche (iCOVID ANR-20-COVI-0025).

Source: Pharmacology
Pharmacology, Karger, 2021, 106 (1-2), pp.9-19. ⟨10.1159/000510251⟩

Subject Terms: Immunoglobulin A, Therapeutic antibody, Bioengineering, Primary antibody deficiency, MESH: Animals, MESH: Anti-Inflammatory Agents / therapeutic use, MESH: Host-Pathogen Interactions, MESH: Humans, MESH: Immunoglobulin A / adverse effects, MESH: Immunoglobulin A / therapeutic use, MESH: Immunotherapy* / adverse effects, MESH: Inflammation / drug therapy, MESH: Inflammation / immunology, MESH: Mice, MESH: Neoplasms / drug therapy, MESH: Neoplasms / immunology, MESH: Antibodies, Monoclonal / adverse effects, MESH: SARS-CoV-2 / immunology, MESH: Antibodies, Monoclonal / therapeutic use, MESH: Antineoplastic Agents, Immunological / therapeutic use, MESH: Antiviral Agents / adverse effects, MESH: Antiviral Agents / therapeutic use, MESH: COVID-19 / drug therapy, MESH: COVID-19 / immunology, MESH: COVID-19 / virology, [SDV.IMM]Life Sciences [q-bio]/Immunology

Access URL: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::6eb83c7f325b6b1b0a3eaa9a88cac25b
https://hal.sorbonne-universite.fr/hal-03139698

9
Academic Journal
SARS-CoV-2 Specific IgG Antibodies Persist Over a 12-Month Period in Oral Mucosal Fluid Collected From Previously Infected Individuals.

Authors: Chellamuthu P; Department of Serology Research and Development, Curative, Monrovia, CA, United States., Angel AN; Department of Serology Research and Development, Curative, Monrovia, CA, United States., MacMullan MA; Department of Serology Research and Development, Curative, Monrovia, CA, United States.; Mork Family Department of Chemical Engineering and Materials Science, Viterbi School of Engineering, University of Southern California, Los Angeles, CA, United States., Denny N; Department of Serology Research and Development, Curative, Monrovia, CA, United States., Mades A; Department of Serology Research and Development, Curative, Monrovia, CA, United States., Santacruz M; Department of Serology Research and Development, Curative, Monrovia, CA, United States., Lopez R; Department of Serology Research and Development, Curative, Monrovia, CA, United States., Bagos C; Department of Serology Research and Development, Curative, Monrovia, CA, United States., Casian JG; Department of Serology Research and Development, Curative, Monrovia, CA, United States., Trettner K; Department of Serology Research and Development, Curative, Monrovia, CA, United States.; Mork Family Department of Chemical Engineering and Materials Science, Viterbi School of Engineering, University of Southern California, Los Angeles, CA, United States., Lopez L; Department of Serology Research and Development, Curative, Monrovia, CA, United States., Nirema N; Department of Serology Research and Development, Curative, Monrovia, CA, United States., Brobeck M; Department of Serology Research and Development, Curative, Monrovia, CA, United States., Kojima N; Department of Medicine, University of California, Los Angeles, Los Angeles, CA, United States., Klausner JD; Department of Population and Public Health Sciences, Keck School of Medicine, University of Southern California, Los Angeles, CA, United States., Turner F; Department of Serology Research and Development, Curative, Monrovia, CA, United States., Slepnev V; Department of Serology Research and Development, Curative, Monrovia, CA, United States., Ibrayeva A; Department of Serology Research and Development, Curative, Monrovia, CA, United States.; Eli and Edythe Broad Center for Regenerative Medicine at the University of Southern California, William Myron Keck School of Medicine, Los Angeles, CA, United States.; Davis School of Gerontology, University of Southern California, Los Angeles, CA, United States.

Source: Frontiers in immunology [Front Immunol] 2021 Dec 09; Vol. 12, pp. 777858. Date of Electronic Publication: 2021 Dec 09 (Print Publication: 2021).

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

Journal Info: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE

MeSH Terms: Antibodies, Viral/*immunology , COVID-19/*immunology , Immunoglobulin G/*immunology , Saliva/*immunology, Adult ; Aged ; Aged, 80 and over ; Cohort Studies ; Female ; Humans ; Longitudinal Studies ; Male ; Middle Aged ; Mouth Mucosa/immunology ; SARS-CoV-2 ; Seroconversion ; Spike Glycoprotein, Coronavirus/immunology

Accede al texto completo
10
Academic Journal
SARS-CoV-2 Antibody Rapid Tests: Valuable Epidemiological Tools in Challenging Settings.

Authors: Saluzzo F; Division of Immunology, Transplantation and Infectious Disease, IRCCS Ospedale San Raffaele, Milano, Italy., Mantegani P; Division of Immunology, Transplantation and Infectious Disease, IRCCS Ospedale San Raffaele, Milano, Italy., Poletti De Chaurand V; Division of Immunology, Transplantation and Infectious Disease, IRCCS Ospedale San Raffaele, Milano, Italy., Quaresima V; Division of Immunology, Transplantation and Infectious Disease, IRCCS Ospedale San Raffaele, Milano, Italy., Cugnata F; CUSSB-University Center for Statistics in the Biomedical Sciences, Vita-Salute San Raffaele Universitygrid.15496.3f, Milano, Italy., Di Serio C; CUSSB-University Center for Statistics in the Biomedical Sciences, Vita-Salute San Raffaele Universitygrid.15496.3f, Milano, Italy., Macé A; Foundation for Innovative New Diagnosticsgrid.452485.a (FIND), Geneva, Switzerland., De Vos M; Foundation for Innovative New Diagnosticsgrid.452485.a (FIND), Geneva, Switzerland., Sacks JA; Foundation for Innovative New Diagnosticsgrid.452485.a (FIND), Geneva, Switzerland., Cirillo DM; Division of Immunology, Transplantation and Infectious Disease, IRCCS Ospedale San Raffaele, Milano, Italy.

Source: Microbiology spectrum [Microbiol Spectr] 2021 Oct 31; Vol. 9 (2), pp. e0025021. Date of Electronic Publication: 2021 Sep 22.

Publication Type: Evaluation Study; Journal Article; Research Support, Non-U.S. Gov't

Journal Info: Publisher: ASM Press Country of Publication: United States NLM ID: 101634614 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2165-0497 (Electronic) Linking ISSN: 21650497 NLM ISO Abbreviation: Microbiol Spectr Subsets: MEDLINE

MeSH Terms: Antibodies, Viral/*blood , COVID-19 Serological Testing/*methods , COVID-19 Vaccines/*immunology , SARS-CoV-2/*immunology , Spike Glycoprotein, Coronavirus/*immunology, Adult ; BNT162 Vaccine ; COVID-19/diagnosis ; Electrochemical Techniques ; Enzyme-Linked Immunosorbent Assay ; Female ; Humans ; Immunoassay/methods ; Immunoglobulin G/blood ; Immunoglobulin M/blood ; Male ; Mass Screening/methods ; Point-of-Care Testing ; Sensitivity and Specificity ; Tuberculosis/diagnosis ; Young Adult

Accede al texto completo
Search Tools: Get RSS Feed — Email this Search